VIR
Vir Biotechnology·NASDAQ
--
--(--)
--
--(--)
6.46 / 10
Outperform
Analyst sentiment is overwhelmingly bullish (Strong Buy rating from HC Wainwright & Co.), yet the fund-flow narrative is more nuanced: while overall liquidity flow is positive (score 7.87/10), the trend is tempered by mitigated block and large-inflow patterns. Investors should reconcile the optimistic analyst view with the still-fragile technical and flow backdrop.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-30
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for VIR?
- VIR holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.46/10 (Outperform).
